Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich Spengler

Showing results (131-140 of 224) with videos related to

Pageof 23
Sort By:
Oncotargets and Therapy|October 17, 2017
Yttrium-90 radioembolization of unresectable hepatocellular carcinoma - a single center experienceCarsten Meyer, Claus Christian Pieper, Hojjat Ahmadzadehfar, et al.
World Journal of Gastroenterology|January 27, 2006
Distribution and effects of polymorphic RANTES gene alleles in HIV/HCV coinfection -- a prospective cross-sectional studyGolo Ahlenstiel, Agathe Iwan, Jacob Nattermann, et al.
European Journal of Gastroenterology & Hepatology|July 13, 2007
Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trialBernd Kronenberger, Thomas Berg, Eva Herrmann, et al.
European Journal of Medical Research|April 14, 2011
Cancer risk in HIV-infected individuals on HAART is largely attributed to oncogenic infections and state of immunocompetenceM Vogel, O Friedrich, G Lüchters, et al.
Hepatology (Baltimore, Md.)|May 30, 2003
Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trialThomas Berg, Bernd Kronenberger, Holger Hinrichsen, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 24, 2015
A variant in the nuclear dot protein 52kDa gene increases the risk for spontaneous bacterial peritonitis in patients with alcoholic liver cirrhosisPhilipp Lutz, Benjamin Krämer, Dominik J Kaczmarek, et al.
Hepatology (Baltimore, Md.)|June 28, 2003
Interleukin 6/gp130-dependent pathways are protective during chronic liver diseasesKonrad L Streetz, Frank Tacke, Ludger Leifeld, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 25, 2011
Importance of minimal residual viremia for relapse prediction in patients with chronic hepatitis C genotype 1 infectionJohannes Wiegand, Konrad Neumann, Stephan Böhm, et al.
Plos One|September 2, 2016
IL-28B Genetic Variants Determine the Extent of Monocyte-Induced Activation of NK Cells in Hepatitis CBenjamin Krämer, Claudia Finnemann, Beatriz Sastre, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 25, 2016
Real-world experience with daclatasvir plus sofosbuvir ± ribavirin for post-liver transplant HCV recurrence and severe liver diseaseKerstin Herzer, Tania M Welzel, Ulrich Spengler, et al.
Pageof 23

Showing results (131-140 of 224) with videos related to

Sort By:
Pageof 23
Oncotargets and Therapy|October 17, 2017
Yttrium-90 radioembolization of unresectable hepatocellular carcinoma - a single center experienceCarsten Meyer, Claus Christian Pieper, Hojjat Ahmadzadehfar, et al.
World Journal of Gastroenterology|January 27, 2006
Distribution and effects of polymorphic RANTES gene alleles in HIV/HCV coinfection -- a prospective cross-sectional studyGolo Ahlenstiel, Agathe Iwan, Jacob Nattermann, et al.
European Journal of Gastroenterology & Hepatology|July 13, 2007
Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trialBernd Kronenberger, Thomas Berg, Eva Herrmann, et al.
European Journal of Medical Research|April 14, 2011
Cancer risk in HIV-infected individuals on HAART is largely attributed to oncogenic infections and state of immunocompetenceM Vogel, O Friedrich, G Lüchters, et al.
Hepatology (Baltimore, Md.)|May 30, 2003
Triple therapy with amantadine in treatment-naive patients with chronic hepatitis C: a placebo-controlled trialThomas Berg, Bernd Kronenberger, Holger Hinrichsen, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|October 24, 2015
A variant in the nuclear dot protein 52kDa gene increases the risk for spontaneous bacterial peritonitis in patients with alcoholic liver cirrhosisPhilipp Lutz, Benjamin Krämer, Dominik J Kaczmarek, et al.
Hepatology (Baltimore, Md.)|June 28, 2003
Interleukin 6/gp130-dependent pathways are protective during chronic liver diseasesKonrad L Streetz, Frank Tacke, Ludger Leifeld, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 25, 2011
Importance of minimal residual viremia for relapse prediction in patients with chronic hepatitis C genotype 1 infectionJohannes Wiegand, Konrad Neumann, Stephan Böhm, et al.
Plos One|September 2, 2016
IL-28B Genetic Variants Determine the Extent of Monocyte-Induced Activation of NK Cells in Hepatitis CBenjamin Krämer, Claudia Finnemann, Beatriz Sastre, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|December 25, 2016
Real-world experience with daclatasvir plus sofosbuvir ± ribavirin for post-liver transplant HCV recurrence and severe liver diseaseKerstin Herzer, Tania M Welzel, Ulrich Spengler, et al.
Pageof 23